Cardiovascular risk factors and cardiovascular diseases in patients with moderate to severe psoriasis under systemic treatment. PSO-RISK, descriptive study. [artículo]
Por: Vanaclocha Sebastián, Francisco [Dermatología Médico Quirúrgica y Venereología]
| Rivera Díaz, Raquel [Dermatología Médico-Quirúrgica y Venereología].
Colaborador(es): Servicio de Dermatología Médico-Quirúrgica y Venereología.
Tipo de material: 
ArtículoEditor: European journal of dermatology : EJD, 2014Descripción: 24(6):662-9.Recursos en línea: Solicitar documento Resumen: Background: The prevalence of cardiovascular risk factors (CVRF) in psoriasis has not been studied in large Spanish samples.
Objective: To assess the prevalence of major CVRFs in psoriasis patients requiring systemic treatments.
Material and methods: Cross-sectional study in psoriasis patients from 33 hospital dermatology offices throughout Spain. Blood pressure (BP) was measured and a fasting lab test was performed. Each CVRF was diagnosed according to the recommendations of international societies.
Results: In 368 patients (mean age 48 years old, 36% women), 80.2% had at least one CVRF. The prevalence of each CVRF was similar in men and women and slightly higher in patients with psoriatic arthritis and in patients with a history of more severe disease. The percentage of patients treated with drugs to control CVRF was low (∼ 50% of those with each CVRF). A total of 20.7% had experienced some cardiovascular disease (CVD) episode.
Conclusion: The prevalence of CVRF was high, higher than in the general Spanish population, and 20% had already suffered CVD. However, the percentage with drug treatments for CVRF was low.
| Tipo de ítem | Ubicación actual | Signatura | Estado | Fecha de vencimiento |
|---|---|---|---|---|
Artículo
|
PC15949 (Navegar estantería) | Disponible |
Formato Vancouver:
Vanaclocha F, Belinchón I, Sánchez-Carazo JL, Rivera R, Carrascosa JM, Cea-Calvo L et al. Cardiovascular risk factors and cardiovascular diseases in patients with moderate to severe psoriasis under systemic treatment. PSO-RISK, descriptive study. Eur J Dermatol. 2014 Nov-Dec;24(6):662-9.
PMID: 25333326
Contiene 36 referencias
Background: The prevalence of cardiovascular risk factors (CVRF) in psoriasis has not been studied in large Spanish samples.
Objective: To assess the prevalence of major CVRFs in psoriasis patients requiring systemic treatments.
Material and methods: Cross-sectional study in psoriasis patients from 33 hospital dermatology offices throughout Spain. Blood pressure (BP) was measured and a fasting lab test was performed. Each CVRF was diagnosed according to the recommendations of international societies.
Results: In 368 patients (mean age 48 years old, 36% women), 80.2% had at least one CVRF. The prevalence of each CVRF was similar in men and women and slightly higher in patients with psoriatic arthritis and in patients with a history of more severe disease. The percentage of patients treated with drugs to control CVRF was low (∼ 50% of those with each CVRF). A total of 20.7% had experienced some cardiovascular disease (CVD) episode.
Conclusion: The prevalence of CVRF was high, higher than in the general Spanish population, and 20% had already suffered CVD. However, the percentage with drug treatments for CVRF was low.
No hay comentarios para este ejemplar.